FindTrial
Sign In

Development of the tailor-maid cancer treatment platform with each cancer optimum RI labeling drugs based on the estimation of optimum dose using a fusion technique of CT and PET image analysis and Monte Carlo dose calculation cord

Development of the tailor-maid cancer treatment platform with each cancer optimum RI labeling drugs based on the estimation of optimum dose using a fusion technique of CT and PET image analysis and Monte Carlo dose calculation cord - Development of the tailor-maid dose estimation platform using CT and PET image analysis and Monte Carlo cord

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000025281
Enrollment
50
Registered
2016-12-26
Start date
2017-01-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

National Institutes for Quantum and Radiological Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients who received PET-CT diagnosis in the medical treatment in the hospital radiation department of the Gunma University medical department

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
Dose estimation—

Countries

Japan

Contacts

Public ContactTetsuya Sakashita

National Institutes for Quantum and Radiological Science and Technology Department of Radiation-Applied Biology Research

sakashita.tetsuya@qst.go.jp027-346-9103

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026